Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 9:10:212.
doi: 10.1186/1471-2180-10-212.

Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs

Affiliations

Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs

Sinu Paul et al. BMC Microbiol. .

Abstract

Background: Epitope vaccines have been suggested as a strategy to counteract viral escape and development of drug resistance. Multiple studies have shown that Cytotoxic T-Lymphocyte (CTL) and T-Helper (Th) epitopes can generate strong immune responses in Human Immunodeficiency Virus (HIV-1). However, not much is known about the relationship among different types of HIV epitopes, particularly those epitopes that can be considered potential candidates for inclusion in the multi-epitope vaccines.

Results: In this study we used association rule mining to examine relationship between different types of epitopes (CTL, Th and antibody epitopes) from nine protein-coding HIV-1 genes to identify strong associations as potent multi-epitope vaccine candidates. Our results revealed 137 association rules that were consistently present in the majority of reference and non-reference HIV-1 genomes and included epitopes of two different types (CTL and Th) from three different genes (Gag, Pol and Nef). These rules involved 14 non-overlapping epitope regions that frequently co-occurred despite high mutation and recombination rates, including in genomes of circulating recombinant forms. These epitope regions were also highly conserved at both the amino acid and nucleotide levels indicating strong purifying selection driven by functional and/or structural constraints and hence, the diminished likelihood of successful escape mutations.

Conclusions: Our results provide a comprehensive systematic survey of CTL, Th and Ab epitopes that are both highly conserved and co-occur together among all subtypes of HIV-1, including circulating recombinant forms. Several co-occurring epitope combinations were identified as potent candidates for inclusion in multi-epitope vaccines, including epitopes that are immuno-responsive to different arms of the host immune machinery and can enable stronger and more efficient immune responses, similar to responses achieved with adjuvant therapies. Signature of strong purifying selection acting at the nucleotide level of the associated epitopes indicates that these regions are functionally critical, although the exact reasons behind such sequence conservation remain to be elucidated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A "multi-type" association rule involving three CTL and one Th epitope from three different genes, Gag, Pol and Nef in reference to HIV-1 genome. The corresponding amino acid coordinates (as per HIV-1 HXB2 reference sequence) and HLA allele supertypes recognizing these epitopes are also shown.
Figure 2
Figure 2
Relative composition of unique association rules involving multiple genes (Gag, Pol and Nef) and epitope types (Cytotoxic T Lymphocyte (CTL), T-Helper (Th) and antibody (Ab) epitopes). The 6142 unique association rules are classified according to the genes that harbor these epitopes. The pie-chart inside each segment represents the division according to the epitope region types involved. The single association rule in Nef-only category involved CTL and Th epitopes, while that in Pol-Env category involved CTL and Ab epitopes. Out of four association rules involving epitopes from Gag and Env, three belonged to CTL-Ab and one belonged to Th-Ab epitope regions types.

Similar articles

Cited by

References

    1. Ross AL, Brave A, Scarlatti G, Manrique A, Buonaguro L. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference. The Lancet Infectious Diseases. 2010;10(5):305–316. doi: 10.1016/S1473-3099(10)70069-4. - DOI - PubMed
    1. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194(1):11–19. doi: 10.1086/505147. - DOI - PubMed
    1. Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clinical Infectious Diseases. 2004;39(9):1380–1384. doi: 10.1086/424883. - DOI - PubMed
    1. Florescu D, Kotler DP. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther. 2007;12(2):149–162. - PubMed
    1. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347(6):385–394. doi: 10.1056/NEJMoa013552. - DOI - PubMed

Publication types

MeSH terms